Showing results (61-70 of 1,363) with videos related to
Sort By:
Pageof 137
Iscience|August 29, 2022
Off-the-shelf third-party HSC-engineered iNKT cells for ameliorating GvHD while preserving GvL effect in the treatment of blood cancersYan-Ruide Li, Samuel Zeng, Zachary Spencer Dunn, et al.Cancers|June 10, 2022
Targeting Immunosuppressive Tumor-Associated Macrophages Using Innate T Cells for Enhanced Antitumor ReactivityYan-Ruide Li, James Brown, Yanqi Yu, et al.Journal of Hematology & Oncology|July 2, 2026
Large language model-guided CAR-T in silico platform for cytokine optimization in liver cancer with low antigen densityHaochen Nan, Xinyuan Shen, Youcheng Yang, et al.Stem Cell Research & Therapy|March 22, 2022
Development of off-the-shelf hematopoietic stem cell-engineered invariant natural killer T cells for COVID-19 therapeutic interventionYan-Ruide Li, Zachary Spencer Dunn, Gustavo Garcia, et al.Cell Reports. Medicine|August 30, 2025
Multimodal targeting of metastatic renal cell carcinoma via CD70-directed allogeneic CAR-NKT cellsYan-Ruide Li, Junhui Hu, Zhe Li, et al.Science Advances|October 18, 2023
A self-assembled implantable microtubular pacemaker for wireless cardiac electrotherapyShaolei Wang, Qingyu Cui, Parinaz Abiri, et al.Nature Protocols|October 9, 2025
Manufacturing synthetic viscoelastic antigen-presenting cells for immunotherapyZeyang Liu, Yan-Ruide Li, Youcheng Yang, et al.View (Beijing, China)|October 31, 2024
Frontiers in artificial intelligence-directed light-sheet microscopy for uncovering biological phenomena and multi-organ imagingEnbo Zhu, Yan-Ruide Li, Samuel Margolis, et al.Cancers|April 12, 2022
Minimally Invasive Preclinical Monitoring of the Peritoneal Cavity Tumor MicroenvironmentZachary Spencer Dunn, Yan-Ruide Li, Yanqi Yu, et al.Journal of Hematology & Oncology|October 12, 2025
Targeting triple-negative breast cancer using cord-blood CD34⁺ HSPC-derived mesothelin-specific CAR-NKT cells with potent antitumor activityYan-Ruide Li, Xinyuan Shen, Yichen Zhu, et al.Pageof 137